Skip to Main Content

Author Details

Leylah M Drusbosky
College of Medicine, University of Florida
2015
31
12
PMIDPaper TitleJournal TitlePublished Year
37962267Characterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.Thyroid2024
37068173Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.Cancer Discov2023
37824798Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing.JCO Precis Oncol2023
34782240Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer.Clin Lung Cancer2022
35350512Atypical Lung Carcinoid With EML4/ALK Fusion Detected With Circulating Tumor DNA.Cureus2022
35766303Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.Prostate2022
35462410Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.Oncologist2022
35961935Oncogene Overlap Analysis of Circulating Cell-free Tumor DNA to Explore the Appropriate Criteria for Defining MET Copy Number-Driven Lung Cancer.Clin Lung Cancer2022
35085983Short communication: The activity of brigatinib in patients with disease progression after next generation anaplastic lymphoma tyrosine kinase inhibitors and an exploratory analysis of circulating tumor DNA.Lung Cancer2022
35083150Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival.Front Oncol2022
33975777EGFR L718V (+)/T790M (-) as a Mechanism of Resistance in Patients with Metastatic Non-small-cell Lung Cancer with EGFR L858R Mutations.Clin Lung Cancer2021
33771190Therapeutic strategies in RET gene rearranged non-small cell lung cancer.J Hematol Oncol2021
33776702Detection of Microsatellite Instability via Circulating Tumor DNA and Response to Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: A Case Series.Case Rep Oncol2021
33555095Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.Oncologist2021
34425853Therapeutic strategies in METex14 skipping mutated non-small cell lung cancer.J Hematol Oncol2021
32397113Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes.Int J Mol Sci2020
32913030Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study.J Immunother Cancer2020
32477464Blood-based next-generation sequencing analysis of neuroendocrine neoplasms.Oncotarget2020
30641417Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomics.Leuk Res2019
31299413Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.Leuk Res2019
31208955A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients.Blood Adv2019
31009835Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis.Leuk Res2019
30642575Predicting response to BET inhibitors using computational modeling: A BEAT AML project study.Leuk Res2019
29175379Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study.Leuk Res2018
29800400Using social media to assess care coordination goals and plans for leukemia patients and survivors.Transl Behav Med2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
29760161CTCF boundary remodels chromatin domain and drives aberrant <i>HOX</i> gene transcription in acute myeloid leukemia.Blood2018
27855285Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical response in patients.Leuk Res2017
28913766Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes.Curr Hematol Malig Rep2017
26898708Chemosensitizing AML cells by targeting bone marrow endothelial cells.Exp Hematol2016
26189107Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition.Leuk Res2015
  • 1 - 31 of 31

Recommended Authors

Mara Rosenberg
Broad Institute of MIT and Harvard
Career Start Year 2013
Number of shared co-authors 24
Yang Shao
Nanjing Geneseeq Technology Inc.
Career Start Year 2012
Number of shared co-authors 1
Noah E Berlow
Children's Cancer Therapy Development Institute
Career Start Year 2011
Number of shared co-authors 1
Arvind Singh Mer
University of Ottawa
Career Start Year 2011
Number of shared co-authors 1
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Christopher A Miller
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Caroline E McCoach
UCSF Helen Diller Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 4
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 2
Alexander Drilon
Memorial Sloan Kettering Cancer Center
Career Start Year 2008
Number of shared co-authors 9
Kilannin Krysiak
Washington University School of Medicine
Career Start Year 2007
Number of shared co-authors 1
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 6
Sadakatsu Ikeda
Tokyo Medical and Dental University Hospital
Career Start Year 2006
Number of shared co-authors 2
Jonathan R Dry
Present Address: Tempus Labs Inc.
Career Start Year 2003
Number of shared co-authors 0
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 1
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 6
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 3
Trever G Bivona
University of California san francisco
Career Start Year 2002
Number of shared co-authors 6
Simon Kreutzfeldt
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2002
Number of shared co-authors 1
Fei Yang
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 17
Nikhil Wagle
Dana-Farber Cancer Institute
Career Start Year 2000
Number of shared co-authors 3
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 4
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 3
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 4
Nikolas von Bubnoff
University Hospital of Schleswig-Holstein
Career Start Year 1997
Number of shared co-authors 4
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 7
Siraj M Ali
Foundation Medicine
Career Start Year 1995
Number of shared co-authors 8
Vincent A Miller
Injury Prevention Research Center, University of North Carolina
Career Start Year 1994
Number of shared co-authors 6
Ultan McDermott
Wellcome Sanger Institute
Career Start Year 1993
Number of shared co-authors 1
Mark J Routbort
University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 6

Collaborators

Christopher R Cogle
College of Medicine, University of Florida
Co-authored papers 14
Taher Abbasi
Cellworks Group Inc.
Co-authored papers 6
Shireen Vali
Cellworks Group Inc.
Co-authored papers 5
Kimberly E Hawkins
College of Medicine, University of Florida
Co-authored papers 3
Brian J Druker
Oregon Health & Science University
Co-authored papers 2
Anay Talawdekar
Cellworks Research India Pvt Ltd
Co-authored papers 2
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 2
Stephen E Kurtz
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 2
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 2
Veronica Clavijo Jordan
Harvard Medical School
Co-authored papers 2
Ronan Swords
Oregon Health and Science University
Co-authored papers 2
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 2
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 2
Nicola Long
Oregon Health and Science University
Co-authored papers 1
Aashis Thapa
Emory School of Medicine
Co-authored papers 1
Russell T Burke
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Abdusebur Jemal
Morehouse School of Medicine
Co-authored papers 1
Bijal Shah
Moffitt Cancer Center
Co-authored papers 1
Robinson Vidva
Cellworks Research India Pvt. Ltd
Co-authored papers 1
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Amanda d'Almeida
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Ryan M Winters
Fox Chase Cancer Center
Co-authored papers 1
James Dibb
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 1
Amanda Winters
University of Colorado School of Medicine
Co-authored papers 1
Elie Traer
Oregon Health & Science University
Co-authored papers 1
Richie Carpenter
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Kim-Hien T Dao
Astex Pharmaceuticals
Co-authored papers 1
Release 1.2